← boothcheck

VTR vs WELL stock comparison

Ventas, Inc. vs WELLTOWER INC., two REIT stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Ventas and Welltower are the two big healthcare REITs, both leveraged to senior-housing occupancy and an aging population, and the market prices Welltower richer: 113 times earnings against Ventas's 161.9, both figures gutted by REIT depreciation and better read through funds from operations. Welltower is nearly four times the size at $165B against $43B, yields less at 1.24% against 2.16%, and generates less free cash, 1.79% against 3.97%. Ventas trades cheaper on book, 3.29 against 3.69, and pays the bigger dividend. Welltower runs 0.40 turns of debt. The two are the closest peers on this page, differing mainly in scale and yield: Welltower the larger, growth-favored name the market pays up for, Ventas the smaller, higher-yielding way into the same demographic bet.

Comparison updated 2026-07-11.

VTR vs WELL: the numbers

MetricVTRWELL
Price$89.03$227.28
Market cap$43.3B$165.1B
SectorREITREIT
StageGrowthGrowth
P/E161.9113.1
P/B3.293.69
P/S7.0714.03
EV/EBITDA30.080.3
Revenue growth+20.6%+37.5%
Net margin4.4%12.4%
Return on equity2.1%3.3%
Return on assets1.0%2.2%
FCF yield4.0%1.8%
Dividend yield2.2%1.2%
Debt / equity0.000.40
Altman Z (solvency)1.674.86
Piotroski F (quality)8 / 97 / 9
Full VTR report → Full WELL report →
Get boothcheck's read on VTR and WELL, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.